Trial intelligence / Profile preview

Glucocorticoids in Energy Homeostasis During Starvation

NCT05919992Phase 1Completed

Start
May 2023
Primary completion
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of metyrapone and hydrocortisone in obesity (2 arms). Primary endpoint: Satiation at 1 week. Started May 2023; status: completed.

02

Drugs

metyraponehydrocortisone
03

Conditions

obesity

Beyond the preview

Go deeper on NCT05919992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05919992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call